Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

270.35 -0.03 (-0.01%)
Streaming Delayed Price Updated: 12:35 PM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
3 No-Brainer Stocks to Buy in a Correction
Stock market downturns present great opportunities to go shopping for wonderful stocks. 
Via The Motley Fool
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
Labcorp's Q1 Revenue Falls On Decline In COVID-19 Testing Sales
 
Via Benzinga
Earnings Outlook For Laboratory Corp
 
Via Benzinga
7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value
Make your dollars go as far as possible (and relatively safely) with these low-PE ratio blue-chip stocks to buy. 
Via InvestorPlace
This Foreboding Sign Looms Over Laboratory Corp's Chart
 
Via Benzinga
Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). 
Via InvestorPlace
Where Laboratory Corp Stands With Analysts
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
Why Enzo Biochem Stock Is Skyrocketing After Hours
Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America 
Via Benzinga
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
From Labcorp
Via Business Wire
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
From Labcorp
Via Business Wire
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Preview: Laboratory Corp
 
Via Benzinga
Hopeful Golden Cross Forms On Laboratory Corp's Chart
 
Via Benzinga
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
From Labcorp
Via Business Wire
Down 40% in 2022, Can Exact Sciences Recover in 2023?
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
From Labcorp
Via Business Wire
6 Analysts Have This to Say About Laboratory Corp
 
Via Benzinga
Analyst Ratings for Laboratory Corp
 
Via Benzinga
4 Analysts Have This to Say About Laboratory Corp
 
Via Benzinga
Expert Ratings for Laboratory Corp
 
Via Benzinga
A Look Into Laboratory Corp's Debt
Over the past three months, shares of Laboratory Corp Inc. (NYSE:LH) increased by 18.45%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at... 
Via Benzinga
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
From Labcorp
Via Business Wire
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
From Labcorp
Via Business Wire
Why Jim Cramer Can't Recommend Investing In Carl Icahn's Company
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Koninklijke Philips NV (NYSE: PHG) is "just not a well-enough run company." He added Danaher Corporation (NYSE: DHR) is the 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
 
Via Benzinga
Labcorp Opens New Los Angeles Based Laboratory
From Labcorp
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.